The treatment of aplastic anemia is the traditional strength of our department, and the combination of Chinese and Western medicine is effective. The western part of our treatment is the same as overseas, and Chinese herbal medicine is effective in treating reoccurrence, but pure Chinese medicine is only suitable for reoccurrence with mild disease. The following is a comprehensive and authoritative guide to the treatment of reoccurrence in the UK, discussing all aspects of the disease from diagnosis to treatment. Progress in recent years: The survival rate of hematopoietic stem cell transplantation for reblastosis is significantly higher than before, with a 10-year disease-free survival of about 85% in young patients (sibling HLA compatible donors), which is better than drug treatment. However, the percentage of transplantation in China is too small because 1) most hematologists do not do transplantation, 2) there are few sibling HLA compatible donors, and 3) patients are worried about the risk of transplantation and the high cost of transplantation. My personal recommendation: for very heavy reoccurrence (granulocytes less than 200) less than 20 years old, HLA compatible siblings or HLA semi-compatible bone marrow transplantation (bone marrow is significantly better than peripheral blood stem cells) should be performed immediately. I strongly disagree because 1, patients with acute leukemia have had quite a few blood transfusions when doing pre-transplant induction and consolidation therapy, is that a contraindication? Those refractory patients who have been in remission for a long time have had even more blood transfusions, is that a contraindication? 2. The intensity of pretreatment for reocclusion is significantly weaker than that for leukemia, which is the most important cause of implantation failure. Properly handled, implantation failure should be controlled at 5%, which is lower than most reports from 10 years ago.